News | January 06, 2026
Abbott unveils Libre Assist to help meal management in diabetics
Abbott’s latest innovation promises to shift diabetes management from reactive to proactive
Abbott’s latest innovation promises to shift diabetes management from reactive to proactive
The interim efficacy readout, involving around 170 participants with 15-month data, remains on track for the end of March 2026
Tolebrutinib had been provisionally approved in the United Arab Emirates in July 2025 for nrSPMS to slow disability accumulation independent of relapse activity
AFib is a progressive condition where timely intervention is critical to disease management and, ultimately, the patient's quality of life
TactiFlex, the world’s first catheter with a flexible tip and contact?force sensing, allows doctors to deliver energy precisely and safely.
The therapy also drove additional weight loss at the higher 1.8 mg dose without plateauing and maintained a favorable tolerability profile
The system is intended for some of the tiniest patients—premature infants weighing as little as two pounds
The announcement came during the inauguration of the college’s Innovation & Incubation Centre and Health Club
Pharmaplan brings a pan-European footprint of locations and specialist teams, now operating within Exyte’s Biopharma & Life Sciences division
The Signia Circular Stapler is the only circular stapler on the market with integrated leak testing and features designed to minimize risk
Subscribe To Our Newsletter & Stay Updated
